SCHEMBL22175381

SCHEMBL22175381

CNCCCCNC1CCCCC1

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.55
CXCR4 P61073 10/20 0.47
CXCL12 P48061 1/20 0.47
HRH4 Q9H3N8 5/20 0.44
HRH3 Q9Y5N1 5/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GNAI3 P08754 2/20 0.41
GNAO1 P09471 2/20 0.41
GNAI1 P63096 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27461328 0.98 SIGMAR1 (0.52) SIGMAR1CXCR4CXCL12HRH4HRH3
SCHEMBL681346 0.95 CXCR4 (0.52) SIGMAR1CXCR4CXCL12HRH4HRH3
SCHEMBL25963986 0.93 SIGMAR1 (0.47) SIGMAR1CXCR4CXCL12HRH4HRH3
SCHEMBL5348992 0.86 RAD52 (0.47) SIGMAR1CXCR4CXCL12HRH3KDM4E
SCHEMBL4739261 0.85 CXCR4 (0.53) CXCR4CXCL12HRH4HRH3KDM4E
SCHEMBL10604006 0.85 CXCR4 (0.53) CXCR4CXCL12HRH4HRH3KDM4E
SCHEMBL4786588 0.85 CXCR4 (0.53) CXCR4CXCL12HRH4HRH3KDM4E
SCHEMBL841438 0.85 CXCR4 (0.53) CXCR4CXCL12HRH4HRH3KDM4E
SCHEMBL4786617 0.85 CXCR4 (0.53) CXCR4CXCL12HRH4HRH3KDM4E
SCHEMBL11520861 0.85 CXCR4 (0.52) CXCR4CXCL12HRH4HRH3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020135765-A1 CXCR4 INHIBITOR AND APPLICATION THEREOF 珠海诺贝尔国际生物医药研究院有限公司 2020-07-02 WO disclosed
CN-1063442-C Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds ZERIA PHARM CO LTD (JP) 2001-03-21 CN disclosed
CN-1184471-A Aminothiazole derivatives, drug containing the same and intermediate in the production of the compounds ZERIA PHARM CO LTD (JP) 1998-06-10 CN disclosed